Evidence map›Paper›PMID 38775343›Full record

ArticleJournal of comparative effectiveness research2024

Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionals.

Maher S Moazin, Abdulaziz Baazeem, Ayman Al-Bakri, Adel Al Dayel, Ashraf Amir, Saud Al Sifri, Mona Reda, Fahad Bashraheel, Abdullah Alfakhri, Yousef Hamdy and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of comparative effectiveness research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maher S MoazinAssistant Professor of Urology, King Saud University for Health Science, Riyadh, Saudi Arabia.
Abdulaziz BaazeemAssociate Professor of Urology, Umm Al-Qura University, Makkah, Saudi Arabia.
Ayman Al-BakriUrology consultant, Male Reproductive Health specialist, Security Forces Hospital, Riyadh, Saudi Arabia.
Adel Al DayelConsultant Urologist/Andrologist, Director of Men's Health Clinic, Dammam, Saudi Arabia.
Ashraf AmirConsultant Family Medicine, International Medical Center, Jeddah, Saudi Arabia.
Saud Al SifriConsultant Endocrinologist, Department of Endocrinology & Diabetes, Alhada Armed Forces Hospital, Taif, Saudi Arabia.
Mona RedaProfessor of Psychiatry, Ain Shams University, Cairo, Egypt.
Fahad BashraheelUrologist/Andrologist, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
Abdullah AlfakhriConsultant Andrology/Male Infertility, King Fahad Medical City - Main Hospital, Riyadh, Saudi Arabia.
Yousef HamdyMedical Advisor, Viatris, Riyadh, Saudi Arabia.
Fayez ElshaerProfessor of Cardiology, King Fahad cardiac center, King Khaled university hospital, King Saud university, Riyadh, Saudi Arabia- National heart institute, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Attitude of Health PersonnelErectile DysfunctionPhosphodiesterase 5 InhibitorsAdultDrug MonitoringHealth PersonnelHumansMaleMiddle AgedSurveys and QuestionnairesPhosphodiesterase 5 Inhibitorserectile dysfunctionphosphodiesterase type 5 inhibitorspoll

Identifiers

PMID38775343
PMCPMC11225304

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.